Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01467843 · ClinicalTrials.gov registry record · Phase 3
Comparison of CAM and Conventional Mind-Body Therapies for Chronic Back Pain
A Phase 3 study of Low Back Pain, sponsored by Kaiser Permanente.
- Completed
- Registry status
- Phase 3
- Development phase
- 342
- Enrollment target
- 1
- Study location
NCT01467843: Completed Phase 3 study of Low Back Pain, sponsored by Kaiser Permanente.
NCT01467843 is a Phase 3 study of Low Back Pain that has completed, run by Kaiser Permanente. The registered enrollment target is 342 participants, below the 501-participant average among 122 other Low Back Pain trials with a reported enrollment target (32% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01467843, a Phase 3 study of Low Back Pain, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 342 participants
- Enrollment target
- 1
- Study location
Study Summary
Although national expenditures on back pain treatments have increased substantially over the past decade, the health and functional status of persons suffering from back pain has deteriorated. This trial will evaluate the effectiveness, and cost-effectiveness, of a safe and relatively inexpensive "mind-body" therapy that has the potential to provide relief to some of the millions of Americans who continue to suffer from chronic back pain.
Primary Outcome
Back-related dysfunction will be measured with the modified Roland Disability Questionnaire ("Roland scale"), which asks whether 23 specific activities were limited due to back pain during the past week (yes or no). This measure has been found to be reliable, valid and sensitive to clinical changes and is appropriate for telephone administration and patients with moderate disability.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy
- BEHAVIORAL Mindfulness Based Stress Reduction
Study Locations (1)
Washington
- Group Health Cooperative - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 342 participants |
| Start Date | 2012-06 |
| Est. Completion | 2015-11 |
| Phase | Phase 3 |
What the finished NCT01467843 record still lists
NCT01467843 is an interventional study that assigns participants to a tested intervention. The registered 342 participants enrollment target is mid-sized for trials with a published cap, below the 501-participant average among 122 other Low Back Pain trials with a reported enrollment target (32% lower).
The record links to 1 condition, with Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Behavioral Therapy is the first listed.
NCT01467843 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT01467843 about?
NCT01467843 is a clinical study titled "Comparison of CAM and Conventional Mind-Body Therapies for Chronic Back Pain". Although national expenditures on back pain treatments have increased substantially over the past decade, the health and functional status of persons suffering from back pain has deteriorated. This trial will evaluate the effectiveness, and cost-effectiveness, of a safe and relatively inexpensive "m...
What is the current status of trial NCT01467843?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 342 participants. The study started on 2012-06. Estimated completion is 2015-11.
What conditions does trial NCT01467843 study?
This clinical trial studies the following conditions: Low Back Pain.
What interventions are being tested in trial NCT01467843?
The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL), Mindfulness Based Stress Reduction (BEHAVIORAL).
Who is sponsoring clinical trial NCT01467843?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01467843 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01467843's enrollment target sits among peer trials
342 21st of 122 higher than 102 of 122 other Low Back Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Low Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nonpharmacologic Pain Management in FQHC Primary Care Clinics
RECRUITING · Phase 3
-
The Use of Methylsulfonylmethane (MSM) in the Treatment of Low Back Pain
COMPLETED · Phase 3
-
Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain
COMPLETED · Phase 3
-
Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain
COMPLETED · Phase 3
-
Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Experienced Subjects
COMPLETED · Phase 3
-
Osteopathic Health Outcomes in Chronic Low Back Pain (OSTEOPATHIC) Trial
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05283850 · 342 participants · Phase 2
Surviving PEA in Roanoke (SPEAR) Study
- NCT05714085 · 342 participants · Phase 2
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- NCT06188702 · 342 participants · Phase 1
S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP
- NCT06544941 · 342 participants · NA
Improving Maternal Sleep and Mental Health
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia